Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exome | 8 | 2021 | 141 | 1.090 |
Why?
|
| Genetic Testing | 5 | 2023 | 565 | 0.740 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 40 | 0.440 |
Why?
|
| Physicians | 1 | 2021 | 682 | 0.420 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 192 | 0.400 |
Why?
|
| Genetic Variation | 4 | 2018 | 1415 | 0.360 |
Why?
|
| Genomics | 4 | 2023 | 848 | 0.340 |
Why?
|
| Computational Biology | 1 | 2014 | 578 | 0.330 |
Why?
|
| Intellectual Disability | 3 | 2016 | 195 | 0.310 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2008 | 14 | 0.290 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2008 | 35 | 0.290 |
Why?
|
| Neuropeptides | 1 | 2008 | 114 | 0.280 |
Why?
|
| Gene Duplication | 1 | 2008 | 128 | 0.270 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 185 | 0.270 |
Why?
|
| Gene Deletion | 1 | 2008 | 352 | 0.260 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2018 | 101 | 0.240 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 537 | 0.230 |
Why?
|
| Glucuronosyltransferase | 2 | 2010 | 184 | 0.220 |
Why?
|
| Gallstones | 1 | 2004 | 21 | 0.210 |
Why?
|
| Fabry Disease | 1 | 2023 | 7 | 0.200 |
Why?
|
| Mutation, Missense | 2 | 2015 | 297 | 0.200 |
Why?
|
| Cohort Studies | 3 | 2021 | 3054 | 0.190 |
Why?
|
| Phenotype | 4 | 2018 | 2544 | 0.190 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 142 | 0.180 |
Why?
|
| De Lange Syndrome | 2 | 2013 | 10 | 0.180 |
Why?
|
| BRCA1 Protein | 1 | 2023 | 214 | 0.180 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2021 | 23 | 0.170 |
Why?
|
| DNA Mutational Analysis | 2 | 2015 | 543 | 0.160 |
Why?
|
| Genome | 1 | 2023 | 407 | 0.150 |
Why?
|
| Genetics, Medical | 1 | 2019 | 51 | 0.150 |
Why?
|
| Loose Anagen Hair Syndrome | 1 | 2018 | 5 | 0.140 |
Why?
|
| Noonan Syndrome | 1 | 2018 | 7 | 0.140 |
Why?
|
| Hypopituitarism | 1 | 2018 | 17 | 0.140 |
Why?
|
| Cleft Palate | 1 | 2018 | 27 | 0.140 |
Why?
|
| Cardiac Myosins | 1 | 2018 | 19 | 0.140 |
Why?
|
| Humans | 23 | 2023 | 93515 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 2465 | 0.130 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 86 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 300 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 797 | 0.120 |
Why?
|
| Histone Acetyltransferases | 1 | 2016 | 45 | 0.120 |
Why?
|
| Genotype | 4 | 2010 | 1866 | 0.120 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 50 | 0.120 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2015 | 49 | 0.110 |
Why?
|
| Bartter Syndrome | 1 | 2015 | 3 | 0.110 |
Why?
|
| Transaminases | 1 | 2015 | 32 | 0.110 |
Why?
|
| Chloride Channels | 1 | 2015 | 43 | 0.110 |
Why?
|
| Genetic Counseling | 1 | 2015 | 101 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 72 | 0.110 |
Why?
|
| Sudden Infant Death | 1 | 2015 | 34 | 0.110 |
Why?
|
| Mutation | 6 | 2016 | 4272 | 0.110 |
Why?
|
| DNA | 2 | 2014 | 1265 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 291 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 103 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 237 | 0.110 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2013 | 5 | 0.100 |
Why?
|
| Micrognathism | 1 | 2013 | 11 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2015 | 172 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2015 | 333 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 4 | 2016 | 893 | 0.090 |
Why?
|
| Cell Cycle Proteins | 2 | 2013 | 409 | 0.080 |
Why?
|
| Glucuronides | 1 | 2010 | 34 | 0.080 |
Why?
|
| Proteins | 2 | 2013 | 803 | 0.080 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 52 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 660 | 0.080 |
Why?
|
| Adult | 5 | 2021 | 27918 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 36 | 0.080 |
Why?
|
| Female | 11 | 2023 | 48702 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 65 | 0.070 |
Why?
|
| Warfarin | 1 | 2009 | 106 | 0.070 |
Why?
|
| Genes | 1 | 2008 | 258 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1762 | 0.070 |
Why?
|
| Base Sequence | 2 | 2015 | 2220 | 0.060 |
Why?
|
| Male | 9 | 2021 | 44557 | 0.060 |
Why?
|
| Algorithms | 1 | 2014 | 1953 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2009 | 457 | 0.060 |
Why?
|
| Dairying | 1 | 2005 | 3 | 0.060 |
Why?
|
| Lactose | 1 | 2005 | 26 | 0.060 |
Why?
|
| Agriculture | 1 | 2005 | 44 | 0.060 |
Why?
|
| Adolescent | 3 | 2021 | 9606 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 531 | 0.050 |
Why?
|
| Age of Onset | 1 | 2004 | 342 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2023 | 83 | 0.050 |
Why?
|
| Alleles | 2 | 2018 | 1139 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1917 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2023 | 173 | 0.050 |
Why?
|
| Direct-To-Consumer Screening and Testing | 1 | 2021 | 3 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2005 | 439 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 10164 | 0.040 |
Why?
|
| Jews | 1 | 2021 | 42 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 962 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2018 | 700 | 0.040 |
Why?
|
| Aging | 1 | 2004 | 727 | 0.040 |
Why?
|
| Child | 2 | 2016 | 7355 | 0.040 |
Why?
|
| Facies | 1 | 2018 | 29 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 482 | 0.040 |
Why?
|
| Karyotype | 1 | 2018 | 34 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2015 | 2479 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2016 | 3829 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2715 | 0.030 |
Why?
|
| Research | 1 | 2019 | 251 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 6930 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2018 | 469 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1922 | 0.030 |
Why?
|
| Specialty Boards | 1 | 2015 | 22 | 0.030 |
Why?
|
| Homozygote | 1 | 2015 | 207 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 291 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2023 | 2441 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 382 | 0.030 |
Why?
|
| Consanguinity | 1 | 2015 | 72 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2015 | 72 | 0.030 |
Why?
|
| Syndrome | 1 | 2015 | 437 | 0.030 |
Why?
|
| Autopsy | 1 | 2015 | 126 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2015 | 211 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 241 | 0.030 |
Why?
|
| Siblings | 1 | 2015 | 108 | 0.030 |
Why?
|
| Medicine | 1 | 2015 | 95 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2015 | 295 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 331 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2015 | 201 | 0.030 |
Why?
|
| Mass Screening | 1 | 2019 | 696 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 4560 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2010 | 2026 | 0.030 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cause of Death | 1 | 2015 | 273 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2013 | 110 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 961 | 0.020 |
Why?
|
| Zebrafish | 1 | 2015 | 339 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2013 | 153 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 373 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 5899 | 0.020 |
Why?
|
| United States | 2 | 2019 | 7622 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 2910 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 2010 | 48 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1713 | 0.020 |
Why?
|
| Glycosylation | 1 | 2010 | 137 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 363 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2009 | 30 | 0.020 |
Why?
|
| Vitamin K Epoxide Reductases | 1 | 2009 | 16 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2C9 | 1 | 2009 | 20 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 216 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2009 | 44 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 579 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 27573 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 3220 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2009 | 68 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2009 | 142 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 1492 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 887 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 456 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 3147 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 1105 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2585 | 0.010 |
Why?
|
| Lactose Tolerance Test | 1 | 2005 | 2 | 0.010 |
Why?
|
| Brain | 1 | 2015 | 2391 | 0.010 |
Why?
|
| Milk | 1 | 2005 | 56 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 1117 | 0.010 |
Why?
|
| Africa | 1 | 2005 | 109 | 0.010 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 49 | 0.010 |
Why?
|
| Europe | 1 | 2005 | 337 | 0.010 |
Why?
|
| Haplotypes | 1 | 2005 | 647 | 0.010 |
Why?
|
| Animals | 2 | 2015 | 28155 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 2484 | 0.010 |
Why?
|